Carbon monoxide intoxication: What we know

被引：25

作者：

Reumuth, Georg ^{[1
]}

Alharbi, Ziyad ^{[2
,3
]}

Houschyar, Khosrow Siamak ^{[4
]}

Kim, Bong-Sung ^{[2
]}

Siemers, Frank ^{[1
]}

Fuchs, Paul Christian ^{[5
]}

Grieb, Gerrit ^{[2
,6
]}

机构：

[1] Trauma Ctr Bergmannstrost, Dept Plast & Hand Surg, Burn Unit, Merseburgerstr 165, D-14089 Berlin, Germany

[2] Rhein Westfal TH Aachen, Dept Plast Surg & Hand Surg, Burn Ctr, Med Fac, D-52074 Aachen, Germany

[3] King Abdullah Med City, Dept Plast Surg, Burn Ctr, Jeddah, Saudi Arabia

[4] Ruhr Univ Bochum, Dept Plast Surg, BG Univ Hosp Bergmannsheil, Burkle de la Camp Pl 1, D-44789 Bochum, Germany

[5] Univ Witten Herdecke, Dept Plast Surg & Hand Surg, Burn Ctr, Ostmerheimerstr 200, D-51109 Cologne, Germany

[6] Charite, Teaching Hosp, Dept Plast Surg & Hand Surg, Gemeinschaftskrankenhaus Havelhoehe, Kladower Damm 221, D-14089 Berlin, Germany

来源：

BURNS | 2019年 / 45卷 / 03期

关键词：

Carbon monoxide; CO intoxication; COHb; HYPERBARIC-OXYGEN THERAPY; EXPOSURE DURATION; MANAGEMENT; LACTATE; CARBOXYHEMOGLOBIN; DIAGNOSIS; PYRUVATE; GLUCOSE; LEVEL; LIFE;

D O I：

10.1016/j.burns.2018.07.006

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Carbon monoxide (CO) is a toxic, color-, taste- and odorless gas with fatal consequences if undetected. Intoxication caused by CO is frequent possibly leading to a high morbidity and mortality. The disease involves multiple organ systems without a typical clinical presentation. The clinical picture is furthermore unrelated to levels of carboxyhemoglobin - the routine biomarker. Therefore the diagnosis and treatment can be very demanding. This article in detail reviews epidemiology, symptoms, diagnosis and the therapy of this multidisciplinary challenge. (C) 2018 Elsevier Ltd and ISBI. All rights reserved.

引用

页码：526 / 530

页数：5

共 50 条

[41] PUBLIC MANAGEMENT - WHAT DO WE KNOW - WHAT SHOULD WE KNOW - AND HOW WILL WE KNOW IT
LYNN, LE
JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 1987, 7 (01) : 178 - 187
[42] Population and consumption - What we know, what we need to know
Kates, RW
ENVIRONMENT, 2000, 42 (03): : 10 - 19
[43] Outcomes in CKD: What We Know and What We Need to Know
Clark, Laura E.
Khan, Izhar
NEPHRON CLINICAL PRACTICE, 2010, 114 (02): : C95 - C102
[44] CIGUATERA - WHAT WE KNOW AND WHAT WE WOULD LIKE TO KNOW
SCHEUER, PJ
MYCOTOXINS AND PHYCOTOXINS 88, 1989, 10 : 265 - 276
[45] Newborn screening conditions: What we know, what we do not know, and how we will know it
Levy, Harvey L.
GENETICS IN MEDICINE, 2010, 12 (12) : S213 - S214
[46] COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
Dhawan, Rahul
Gundry, Rebekah L.
Brett-Major, David M.
Mahr, Claudius
Thiele, Geoffrey M.
Lindsey, Merry L.
Anderson, Daniel R.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 144 : 12 - 14
[47] Trust in maps: what we know and what we need to know
Prestby, Timothy J.
CARTOGRAPHY AND GEOGRAPHIC INFORMATION SCIENCE, 2025, 52 (01) : 1 - 18
[48] Garlic - What we know and what we don't know
Charlson, Mary
McFerren, Marcus
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (04) : 325 - 326
[49] EMMY trial: What we know and what we need to know
Jaiswal, Arvind
Chaurasia, Swati
Pradhan, Akshyaya
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (10) : 4145 - 4148
[50] We know what they think, but do we know what they do?
Callingham, M
Baker, T
INTERNATIONAL JOURNAL OF MARKET RESEARCH, 2002, 44 (03) : 299 - 335

← 1 2 3 4 5 →